2.8 per cent is nothing, still higher than ASX close.Governments are making supply deals with many companies in case they come up with a vaccine or antiviral that is effective .The point being is that they still have to prove efficacy in a phase 3 trial .Meso is currently doing that and has had remarkable success from treating patients through compassionate use prior to the current trial. Moreover worth noting that Remestemcel is being used to treat patients with Covid - ARDS and not for any other COVID symptoms .
2.8 per cent is nothing, still higher than ASX close.Governments...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.045(3.83%) |
Mkt cap ! $1.290B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.12 | $12.16M | 10.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 50650 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 124897 | 8 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
-0.045 ( 4.33 %) |
||||
| Open | High | Low | Volume | ||
| $1.17 | $1.17 | $1.12 | 1447014 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| MSB (ASX) Chart |